Potential mechanisms of human recombinant arginase I (Co)-PEG5000 [HuArgI (CO) - PRG5000] induced cytotoxicity in glioblastoma cells. (c2018)

Glioblastoma multiforme (GBM) is a highly aggressive glioma arising in the central nervous system accounting for more than 70% of all brain tumors. Due to the resistance and complexity of the tumor itself, it is characterized by a low survival rate and decreased prognosis. Therefore, more selective...

Full description

Saved in:
Bibliographic Details
Main Author: El Jawhari, Yassmine (author)
Format: masterThesis
Published: 2018
Subjects:
Online Access:http://hdl.handle.net/10725/8650
https://doi.org/10.26756/th.2018.101
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513485387333632
author El Jawhari, Yassmine
author_facet El Jawhari, Yassmine
author_role author
dc.creator.none.fl_str_mv El Jawhari, Yassmine
dc.date.none.fl_str_mv 2018-10-17T07:01:54Z
2018-10-17T07:01:54Z
2018
2018-10-17
2018-06-23
dc.identifier.none.fl_str_mv http://hdl.handle.net/10725/8650
https://doi.org/10.26756/th.2018.101
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php
dc.language.none.fl_str_mv en
dc.publisher.none.fl_str_mv Lebanese American University
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Lebanese American University -- Dissertations
Dissertations, Academic
Glioblastoma multiforme
Arginine -- Therapeutic use
dc.title.none.fl_str_mv Potential mechanisms of human recombinant arginase I (Co)-PEG5000 [HuArgI (CO) - PRG5000] induced cytotoxicity in glioblastoma cells. (c2018)
dc.type.none.fl_str_mv Thesis
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/masterThesis
description Glioblastoma multiforme (GBM) is a highly aggressive glioma arising in the central nervous system accounting for more than 70% of all brain tumors. Due to the resistance and complexity of the tumor itself, it is characterized by a low survival rate and decreased prognosis. Therefore, more selective and efficient therapeutic methods for targeting GBM are needed. In this study, we attempted to investigate the potency of arginine depletion to target GBM cells through the use of human recombinant Arginase I cobalt [HuArgI(Co)] coupled with polyethylene glycol 5000 [HuArgI (Co)-PEG5000]. Cytotoxicity of [HuArgI (Co)-PEG5000] was tested on two GBM cell lines, namely A172 and U251. Both cell lines showed increased sensitivity at longer incubation periods of [HuArgI (Co)-PEG5000] treatment with IC50 values in the pM range, a result attributable to the arginine auxotrophy expressed in those two cell lines. The addition of chloroquine, an autophagy inhibitor, increased the sensitivity of cells to [HuArgI (Co)-PEG5000]-mediated arginine depletion at earlier time points. We also concluded that autophagy was activated in response to arginine depletion and plays a protective role at early time points. However, the excessive accumulation of intracellular autophagosomes upon treatment with chloroquine at later time points illustrates the role of autophagy in response to [HuArgI (Co)-PEG5000]-mediated arginine depletion resulting in ultimate cell death by autophagy. Overall, in this study we showed how arginine auxotrophy in GBM could be used to target such cells through HuArgI (Co)-PEG5000. Hence, HuArgI (Co)-PEG5000 is an efficient and selective therapeutic method for targeting GBM.
eu_rights_str_mv openAccess
format masterThesis
id LAURepo_b659d7fa3899b1cb04cc60de1030ea8f
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/8650
publishDate 2018
publisher.none.fl_str_mv Lebanese American University
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Potential mechanisms of human recombinant arginase I (Co)-PEG5000 [HuArgI (CO) - PRG5000] induced cytotoxicity in glioblastoma cells. (c2018)El Jawhari, YassmineLebanese American University -- DissertationsDissertations, AcademicGlioblastoma multiformeArginine -- Therapeutic useGlioblastoma multiforme (GBM) is a highly aggressive glioma arising in the central nervous system accounting for more than 70% of all brain tumors. Due to the resistance and complexity of the tumor itself, it is characterized by a low survival rate and decreased prognosis. Therefore, more selective and efficient therapeutic methods for targeting GBM are needed. In this study, we attempted to investigate the potency of arginine depletion to target GBM cells through the use of human recombinant Arginase I cobalt [HuArgI(Co)] coupled with polyethylene glycol 5000 [HuArgI (Co)-PEG5000]. Cytotoxicity of [HuArgI (Co)-PEG5000] was tested on two GBM cell lines, namely A172 and U251. Both cell lines showed increased sensitivity at longer incubation periods of [HuArgI (Co)-PEG5000] treatment with IC50 values in the pM range, a result attributable to the arginine auxotrophy expressed in those two cell lines. The addition of chloroquine, an autophagy inhibitor, increased the sensitivity of cells to [HuArgI (Co)-PEG5000]-mediated arginine depletion at earlier time points. We also concluded that autophagy was activated in response to arginine depletion and plays a protective role at early time points. However, the excessive accumulation of intracellular autophagosomes upon treatment with chloroquine at later time points illustrates the role of autophagy in response to [HuArgI (Co)-PEG5000]-mediated arginine depletion resulting in ultimate cell death by autophagy. Overall, in this study we showed how arginine auxotrophy in GBM could be used to target such cells through HuArgI (Co)-PEG5000. Hence, HuArgI (Co)-PEG5000 is an efficient and selective therapeutic method for targeting GBM.N/A1 hard copy: xii, 47 leaves; 30 cm. available at RNL.Bibliography : leaves 38-47.Lebanese American University2018-10-17T07:01:54Z2018-10-17T07:01:54Z20182018-10-172018-06-23Thesisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesishttp://hdl.handle.net/10725/8650https://doi.org/10.26756/th.2018.101http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.phpeninfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/86502021-03-19T10:45:30Z
spellingShingle Potential mechanisms of human recombinant arginase I (Co)-PEG5000 [HuArgI (CO) - PRG5000] induced cytotoxicity in glioblastoma cells. (c2018)
El Jawhari, Yassmine
Lebanese American University -- Dissertations
Dissertations, Academic
Glioblastoma multiforme
Arginine -- Therapeutic use
status_str publishedVersion
title Potential mechanisms of human recombinant arginase I (Co)-PEG5000 [HuArgI (CO) - PRG5000] induced cytotoxicity in glioblastoma cells. (c2018)
title_full Potential mechanisms of human recombinant arginase I (Co)-PEG5000 [HuArgI (CO) - PRG5000] induced cytotoxicity in glioblastoma cells. (c2018)
title_fullStr Potential mechanisms of human recombinant arginase I (Co)-PEG5000 [HuArgI (CO) - PRG5000] induced cytotoxicity in glioblastoma cells. (c2018)
title_full_unstemmed Potential mechanisms of human recombinant arginase I (Co)-PEG5000 [HuArgI (CO) - PRG5000] induced cytotoxicity in glioblastoma cells. (c2018)
title_short Potential mechanisms of human recombinant arginase I (Co)-PEG5000 [HuArgI (CO) - PRG5000] induced cytotoxicity in glioblastoma cells. (c2018)
title_sort Potential mechanisms of human recombinant arginase I (Co)-PEG5000 [HuArgI (CO) - PRG5000] induced cytotoxicity in glioblastoma cells. (c2018)
topic Lebanese American University -- Dissertations
Dissertations, Academic
Glioblastoma multiforme
Arginine -- Therapeutic use
url http://hdl.handle.net/10725/8650
https://doi.org/10.26756/th.2018.101
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php